Question: PARP inhibitor resistance mechanisms and reversal strategies
WEE1 inhibitor plus PARPi combination protocol in resistant BRCA-mutant ovarian cancer
Needs new evidence
1/4 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected